Trasplante cardíaco
Other Titles: 
Heart transplant
Heart transplant
Acute rejection
Chronic disease of the graft
Issue Date: 
Gobierno de Navarra. Departamento de Salud
Ubilla M, Mastrobuoni S, Martin Arnau A, Cordero A, Alegria E, Gavira JJ, et al. Trasplante cardíaco. An Sist Sanit Navar 2006;29 Suppl 2:63-78.
A heart transplant is at present considered the treatment of choice in cases of terminal cardiac insufficiency refractory to medical or surgical treatment. Due to factors such as the greater life expectancy of the population and the more efficient management of acute coronary syndromes, there is an increasing number of people who suffer from heart failure. It is estimated that the prevalence of the disease in developed countries is around 1%; of this figure, some 10% are in an advanced stage and are thus potential receptors of a heart transplant. The problem is that it is still not possible to offer this therapeutic form to all of the patients that require it. Consequently, it is necessary to optimise the results of the heart transplant through the selection of patients, selection and management of donors, perioperative management and control of the disease due to graft rejection. Since the first transplant carried out in 1967, numerous advances and changes have taken place, which has made it possible to increase survival and quality of life of those who have received a new heart. In this article we review the most relevant aspects of the heart transplant and the challenges that are currently faced.

Files in This Item:
An Sist Sanit Navrar 2006 63. Suppl..pdf
102.03 kB
Adobe PDF

Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.